Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
£80m bulk purchase annuity buy-in secures the benefits of more than 350 deferred members and 1,450 pensioners.
The latest results of the Milliman Pension Buyout Index (MPBI) suggest that during January, the estimated cost to transfer retiree pension risk to an insurer in a competitive bidding process in the US inched up 10 basis points, from 100.3% to 100.4% of a plan’s accounting liabilities.
£270m bulk purchase annuity buy-in secures the pension scheme benefits of over 3,200 members of the scheme.
The US pension risk transfer market closed 2025 on a strong note, with fourth-quarter premium estimated at approximately $28bn, making it one of the largest quarters on record, according to Banner Life William Penn’s Q4 2025 US PRT Monitor.
Gilts-based investment approach is feeding through to the prices offered to pension schemes entering BPA transactions by insurers.
The UK’s equity release securitisation market has re-emerged in recent years as a tool in a life insurer’s capital optimisation effort.
Fitch Ratings has a ‘neutral’ outlook for North American life insurers for 2026 despite a more challenging backdrop.
Greg Winterton caught up with Dr. Joshua Funder, CEO and Managing Director of Household Capital, to discuss the current state of and outlook for the reverse mortgage sector of the Australian securitisation market in this month’s Q&A.
Bodycote UK’s Pension Scheme has completed a £60m bulk purchase annuity buy-in with PIC. The transaction secures the benefits of all 680 scheme members.
€1.3bn longevity swap reinsurance agreement covers a portion of the defined benefit pensions included in a pension buy‑out and marks Pacific Life Re’s second longevity reinsurance transaction in the Netherlands.